Baricitinib Curative Repression of HIV-1

Clinical trial NCT07209267 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07209267
Sponsor: Emory University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

HIV Infection HIV

Start date: 2026-10-01
Primary completion: 2028-01-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.